Effects of parity on pregnancy hormonal profiles across ethnic groups with a diverse incidence of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 11, 2006, Pages 2123-2130

  Arslan, Alan A ^a,b   Zeleniuch Jacquotte, Anne ^a,b   Lukanova, Annekatrin ^a,b   Afanasyeva, Yelena ^a   Katz, Joseph ^a   Levitz, Mortimer ^a   Del Priore, Giuseppe ^c   Toniolo, Paolo ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c NEW YORK DOWNTOWN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRADIOL; PROLACTIN; SOMATOMEDIN C;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; BLOOD SAMPLING; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; ETHNIC DIFFERENCE; FEMALE; GESTATIONAL AGE; HISPANIC; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; NEWBORN; PARITY; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SECOND TRIMESTER PREGNANCY;

ADULT; ALPHA-FETOPROTEINS; BREAST NEOPLASMS; CHORIONIC GONADOTROPIN; ESTRADIOL; ETHNIC GROUPS; FEMALE; GESTATIONAL AGE; HORMONES; HUMANS; IMMUNOASSAY; INCIDENCE; PARITY; PREGNANCY; PROLACTIN;

EID: 33845309148     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0470     Document Type: Article

References (48)

1. Surveillance, Epidemiology and End Results (SEER) Program. SEER breast cancer incidence by race 1992-2002. http://seer.cancer.gov/. 2006.
2. Gordon NH. Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 2003;22:55-65.
3. Li CI. Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States. Ethn Dis 2005;15:S5-9.
4. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47.
5. Merrill RM, Fugal S, Novilla LB, et al. Cancer risk associated with early and late maternal age at first birth. Gynecol Oncol 2005;96:583-93.
6. Russo J, Russo IH. The etiopathogenesis of breast cancer prevention. Cancer Lett 1995;90:81-9.
7. Russo IH, Russo J. Hormonal approach to breast cancer prevention. J Cell Biochem Suppl 2000;34:1-6.
8. Jacobson HI, Bennett JA, Mizejewski GJ. Inhibition of estrogen-dependent breast cancer growth by a reaction product of α-fetoprotein and estradiol. Cancer Res 1990;50:415-20.
9. Richardson BE, Hulka BS, Peck JL, et al. Levels of maternal serum α-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk. Am J Epidemiol 1998;148:719-27.
10. Melbye M, Wohlfahrt J, Lei U, et al. α-Fetoprotein levels in maternal serum during pregnancy and maternal breast cancer incidence. J Natl Cancer Inst 2000;92:1001-5.
11. Vakharia D, Mizejewski GJ. Human α-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 2000;63:41-52.
12. Lambe M, Trichopoulos D, Hsieh CC, et al. Ethnic differences in breast cancer risk: a possible role for pregnancy levels of α-fetoprotein? Epidemiology 2003;14:85-9.
13. Musey VC, Collins DC, Musey PI, et al. Long-term effect of a first pregnancy on the secretion of prolactin. N Engl J Med 1987;316:229-34.
14. Wang DY, de Stavola BL, Bulbrook RD, et al. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women. Eur J Cancer Clin Oncol 1988;24:1225-31.
15. Lipworth L, Hsieh CC, Wide L, et al. Maternal pregnancy hormone levels in an area with a high incidence (Boston, USA) and in an area with a low incidence (Shanghai, China) of breast cancer. Br J Cancer 1999;79:7-12.
16. Wuu J, Hellerstein S, Lipworth L, et al. Correlates of pregnancy oestrogen, progesterone and sex hormone-binding globulin in the USA and China. Eur J Cancer Prev 2002;11:283-93.
17. Xu B, Lipworth L, Wide L, et al. Maternal and gestational correlates of pregnancy prolactin and growth hormone in USA and China. Eur J Cancer Prev 2003;12:35-42.
18. Lagiou P, Samoli E, Lagiou A, et al. Maternal height, pregnancy estriol and birth weight in reference to breast cancer risk in Boston and Shanghai. Int J Cancer 2005;117:494-8.
19. Potischman N, Troisi R, Thadhani R, et al. Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:1514-20.
20. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 1990;11:1849-55.
21. Hennighausen L, Robinson GW, Wagner KU, et al. Prolactin signaling in mammary gland development. J Biol Chem 1997;272:7567-9.
22. Anderson E, Clarke RB, Howell A. Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia 1998;3:23-35.
23. Westley BR, Clayton SJ, Daws MR, et al. Interactions between the oestrogen and insulin-like growth factor signalling pathways in the control of breast epithelial cell proliferation. Biochem Soc Symp 1998;63:35-44.
24. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979;74:829-36.
25. Bernstein L, Depue RH, Ross RK, et al. Higher maternal levels of free estradiol in first compared with second pregnancy: early gestational differences. J Natl Cancer Inst 1986;76:1035-9.
26. Panagiotopoulou K, Katsouyanni K, Petridou E, et al. Maternal age, parity, and pregnancy estrogens. Cancer Causes Control 1990;1:119-24.
27. Bogart MH, Jones OW, Felder RA, et al. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 pregnancies. Am J Obstet Gynecol 1991;165:663-7.
28. Benn PA, Clive JM, Collins R. Medians for second-trimester maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol; differences between races or ethnic groups. Clin Chem 1997;43:333-7.
29. O'Brien JE, Dvorin E, Drugan A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening: α-fetoprotein, hCG, and estriol. Obstet Gynecol 1997;89:355-8.
30. Spencer K, Ong CY, Liao AW, et al. The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities. Prenat Diagn 2000;20:491-4.
31. Shibata A, Harris DT, Billings PR. Concentrations of estrogens and IGFs in umbilical cord blood plasma: a comparison among Caucasian, Hispanic, and Asian-American females. J Clin Endocrinol Metab 2002;87:810-5.
32. Shimizu H, Ross RK, Bernstein L, et al. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963-6.
33. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-27.
34. Wu AH, Ziegler RG, Pike MC, et al. Menstrual and reproductive factors and risk of breast cancer in Asian-Americans. Br J Cancer 1996;73:680-6.
35. Bernstein L, Pike MC, Ross RK, et al. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985;74:741-5.
36. Bernstein L, Lipworth L, Ross RK, et al. Correlation of estrogen levels between successive pregnancies. Am J Epidemiol 1995;142:625-8.
37. Petrakis NL, Wrensch MR, Ernster VL, et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987;40:587-91.
38. Musey VC, Collins DC, Brogan DR, et al. Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J Clin Endocrinol Metab 1987;64:111-8.
39. Haddow JE, Palomaki GE, Knight GJ. Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening. J Med Screen 1995;2:28-30.
40. Mooney RA, Arvan DA, Saller DN, Jr., et al. Decreased maternal serum hCG levels with increasing gravidity and parity. Obstet Gynecol 1995;86:900-5.
41. Barkai G, Goldman B, Ries L, et al. Effect of gravidity on maternal serum markers for Down's syndrome. Prenat Diagn 1996;16:319-22.
42. Wald NJ, Watt HC. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Prenat Diagn 1996;16:699-703.
43. Yu MC, Gerkins VR, Henderson BE, et al. Elevated levels of prolactin in nulliparous women. Br J Cancer 1981;43:826-31.
44. Peck JD, Hulka BS, Poole C, et al. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev 2002;11:361-8.
45. Dornhorst A, Paterson CM, Nicholls JS, et al. High prevalence of gestational diabetes in women from ethnic minority groups. Diabet Med 1992;9:820-5.
46. Shelley-Jones DC, Wein P, Nolan C, et al. Why do Asian-born women have a higher incidence of gestational diabetes? An analysis of racial differences in body habitus, lipid metabolism and the serum insulin response to an oral glucose load. Aust N Z J Obstet Gynaecol 1993;33:114-8.
47. Cheung NW, Wasmer G, Al Ali J. Risk factors for gestational diabetes among Asian women. Diabetes Care 2001;24:955-6.
48. Thorpe LE, Berger D, Ellis JA, et al. Trends and racial/ethnic disparities in gestational diabetes among pregnant women in New York City, 1990-2001. Am J Public Health 2005;95:1536-9.